Exstrophy-epispadias Complex
What's New
Last Posted: Feb 27, 2023
- Variants in ALX4 and their association with genitourinary defects.
Chen Ching H, et al. Andrology 2020 0 (5) 1243-1255 - Microduplications at 22q11.21 are associated with non-syndromic classic bladder exstrophy.
Draaken Markus, et al. European journal of medical genetics 2010 0 (2) 55-60 - Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy.
Draaken Markus, et al. PLoS genetics 2015 3 (3) e1005024 - Bladder exstrophy-epispadias complex and the role of methylenetetrahydrofolate reductase C677T polymorphism: A case control study.
Raman Venkat Shankar, et al. Journal of Indian Association of Pediatric Surgeons 0 0 (1) 28-32 - WNT3 involvement in human bladder exstrophy and cloaca development in zebrafish.
Baranowska Körberg Izabella, et al. Human molecular genetics 2015 9 (18) 5069-78 - Genome-wide association study and mouse expression data identify a highly conserved 32 kb intergenic region between WNT3 and WNT9b as possible susceptibility locus for isolated classic exstrophy of the bladder.
Reutter Heiko, et al. Human molecular genetics 2014 10 (20) 5536-44 - No TAP63 promoter mutation is detected in bladder exstrophy-epispadias complex patients.
Darling T, et al. Journal of pediatric surgery 2013 12 (12) 12 - Candidate gene association study implicates p63 in the etiology of nonsyndromic bladder-exstrophy-epispadias complex.
Qi Lihong, et al. Birth defects research. Part A, Clinical and molecular teratology 2013 12 (12) 759-63 - Insertion/deletion polymorphisms in the ?Np63 promoter are a risk factor for bladder exstrophy epispadias complex.
Wilkins S, et al. PLoS genetics 2012 12 (12) 12 - Exstrophy-epispadias complex
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: